Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation.

British Journal of Pharmacology
B J WhittleD D Rees

Abstract

1. The effects of the specific inhibitor of nitric oxide (NO) formation, NG-monomethyl-L-arginine (L-NMMA), on resting systemic arterial blood pressure (BP) and on the actions of both endothelium-dependent and endothelium-independent vasodilators were investigated in the anaesthetized, normotensive rat. 2. Intravenous administration of L-NMMA (12.5-50 mg kg-1; 47-188 mumol kg-1) but not its enantiomer, D-NMMA, induced a dose-related increase in BP, which was reversed by the intravenous administration of L-arginine (150-600 mumol kg-1), but not D-arginine. 3. The vasodepressor responses to intravenous administration of the endothelium-dependent vasodilators, acetylcholine, bradykinin and substance P were significantly inhibited by L-NMMA (94 and 188 mumol kg-1 i.v.), but not by D-NMMA. 4. The inhibition by L-NMMA of these vasodepressor responses was reversed by administration of L-arginine, but not D-arginine. 5. Endothelin (ET-1) induced dose-related vasodepressor responses following bolus intravenous administration, which were significantly inhibited by L-NMMA but not by D-NMMA. This inhibition was reversed by administration of L-arginine. 6. The vasodepressor effects of the endothelium-independent vasodilators, glyceryl trini...Continue Reading

References

Mar 1, 1988·British Journal of Pharmacology·M Feletou, P M Vanhoutte
Jan 1, 1989·Journal of Cardiovascular Pharmacology·B J WhittleJ V Esplugues
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D D ReesS Moncada
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M YanagisawaK Goto
May 1, 1988·Clinical and Experimental Pharmacology & Physiology·C G SobeyG J Dusting
Jul 15, 1988·Biochemical and Biophysical Research Communications·M KelmJ Schrader
Jun 30, 1988·Biochemical and Biophysical Research Communications·R M PalmerS Moncada
Sep 23, 1987·European Journal of Pharmacology·P J HutchinsonS Moncada
Nov 1, 1983·Circulation Research·R F Furchgott

❮ Previous
Next ❯

Citations

Sep 6, 2003·Advances in Therapy·Mohamed A IbrahimShiro Ueda
Sep 21, 1990·European Journal of Pharmacology·P S LidburyJ R Vane
Dec 4, 1990·European Journal of Pharmacology·S R HughesS D Brain
Dec 4, 1990·European Journal of Pharmacology·N K Boughton-SmithS Moncada
Feb 11, 1992·European Journal of Pharmacology·A IalentiM Di Rosa
Dec 15, 1992·European Journal of Pharmacology·S J KonturekB Slomiany
Oct 20, 1992·European Journal of Pharmacology·H P KuoP J Barnes
Apr 1, 1994·European Journal of Pharmacology·K Gyires
Jan 4, 1994·European Journal of Pharmacology·N SatakeS Shibata
Feb 1, 1996·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·A HrabákA Temesi
Nov 1, 1994·General Pharmacology·A Albino-Teixeira, P Soares-da-Silva
Aug 1, 1994·Journal of the American College of Cardiology·T J AndersonA C Yeung
Jan 1, 1993·International Journal of Antimicrobial Agents·J Verhoef
Jan 17, 2004·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Paul A DabischPhilip J Kadowitz
Aug 23, 2001·Pharmacology & Therapeutics·P W Hadoke
Jan 1, 1996·Pharmacology & Therapeutics·G A Gray, D J Webb
Mar 18, 2000·Neuroscience Research·N Yonehara, M Yoshimura
Jan 1, 1997·Journal of the American College of Cardiology·Y Nishikawa, S Ogawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.